Alterity issues 18M unlisted employee options

Alterity Therapeutics Limited has issued 18,000,000 new unlisted options under its employee incentive scheme.

Rhea-AI Filing Summary

Alterity Therapeutics Limited has issued 18,000,000 new unlisted options under its employee incentive scheme. These options have an exercise price of AUD 0.008 and expire on 9 January 2031, and on exercise will convert into ordinary fully paid ATH shares.

The options form a new unquoted security class that is not intended to be quoted on ASX, and all options in this class rank equally from the issue date of 15 January 2026. The filing also notes that this report is incorporated by reference into Alterity’s existing Form S-8 and Form F-3 registration statements.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Alterity Therapeutics (ATHE) announce in this Form 6-K?

Alterity Therapeutics announced the issue of new unlisted options under its employee incentive scheme and furnished this information as part of a Form 6-K, which is also incorporated by reference into its existing Form S-8 and Form F-3 registration statements.

How many new options did Alterity Therapeutics (ATHE) issue and on what date?

The company issued 18,000,000 new unlisted options on 15 January 2026 as part of its employee incentive scheme.

What are the key terms of the new Alterity Therapeutics (ATHE) options?

The new options are unlisted, have an exercise price of AUD 0.008 and an expiry date of 9 January 2031. Upon exercise, they will result in the issue of ordinary fully paid ATH shares.

Are the new Alterity Therapeutics (ATHE) options quoted on ASX?

No. The options are a new class of unquoted securities issued under an employee incentive scheme and are not intended to be quoted on ASX.

Do all the new Alterity Therapeutics (ATHE) options rank equally?

Yes. The filing states that all securities issued in this new option class rank equally in all respects from their issue date.

What is the impact on Alterity Therapeutics (ATHE) capital structure from this option issue?

The filing shows that these 18,000,000 unlisted options are added as a new unquoted class alongside existing quoted and unquoted securities, with ordinary fully paid shares (ATH) and various other option series already on issue.

Were any of the new Alterity Therapeutics (ATHE) options issued to key management personnel?

No. The document states that none of the options in this new class were issued to key management personnel or their associates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/15/2026 - 06:31 AM EST Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-163

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of January 15, 2026

Alterity Therapeutics Limited

(Name of Registrant)

Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒       Form 40-F ☐

This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and our Registration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076)

ALTERITY THERAPEUTICS LIMITED

(a development stage enterprise)

The following exhibits are submitted:

99.1 Notification regarding unquoted securities - ATH

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Alterity Therapeutics Limited
	By:	/s/ Julian Babarczy
		Julian Babarczy
		Chairman

Date: January 15, 2026

2

Exhibit 99.1

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

Announcement Summary

Entity name

ALTERITY THERAPEUTICS LIMITED

Date of this announcement

Thursday January 15, 2026

The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

Total number of +securities to be issued/transferred

ASX +security code		Security description		Total number of +securities to be issued/transferred		Issue date
New class - code to be confirmed		Unlisted options expiring 9 January 2031 ex $0.008		18,000,000		15/01/2026

Refer to next page for full details of the announcement

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 1 / 6

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

Part 1 - Entity and announcement details

1.1 Name of entity

ALTERITY THERAPEUTICS LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

	1.2 Registered number type		Registration number
	ABN		37080699065

1.3 ASX issuer code

ATH

1.4 The announcement is

New announcement

1.5 Date of this announcement

15/1/2026

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 2 / 6

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:

does not have an existing ASX security code (“new class”)

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 3 / 6

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

Part 3C - number and type of +securities the subject of this notification (new class)

	ASX +security code		+Security description
	New class - code to be confirmed		Unlisted options expiring 9 January 2031 ex $0.008

	+Security type		ISIN code
	Options

Date the +securities the subject of this notification were issued

15/1/2026

Will all the +securities issued in this class rank equally in all respects from their issue date?

Yes

Were any of the +securities issued to +key management personnel (KMP) or an +associate?

No

Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1?

No

Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being issued.

Options Details

	+Security currency		Exercise price		Expiry date
	AUD - Australian Dollar		AUD 0.00800000		9/1/2031

Details of the existing class of +security that will be issued upon exercise or conversion of this new class of company option

ATH : ORDINARY FULLY PAID

Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms

https://app.sharelinktechnologies.com/announcement-preview/asx/0e52c57244a1691e13a67c0caf2d50fb

Any other information the entity wishes to provide about the +securities the subject of this notification

Issue details

Number of +securities

18,000,000

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 4 / 6

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

Part 4 - +Securities on issue

Following the issue, conversion or payment up of the +securities the subject of this notification, the +securities of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity’s current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (Total number of each +class of +securities issued and quoted on ASX)

		Total number of
ASX +security code and description		+securities on issue
ATH : ORDINARY FULLY PAID			10,875,416,329
ATHO : OPTION EXPIRING 31-AUG-2026			931,232,089
ATHOA : OPTION EXPIRING 26-FEB-2027			1,222,300,911

4.2 Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX) 

		Total number of
ASX +security code and description		+securities on issue
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375			10,000,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238			11,500,000
ATHAE : OPTION EXPIRING 08-AUG-2030 EX $0.013			11,500,000
ATHAF : OPTION EXPIRING 08-AUG-2030 EX USD 0.0086			312,400,200
ATHAD : OPTION EXPIRING 01-JUL-2030 EX $0.01			15,000,000
ATHAAK : OPTION EXPIRING 30-DEC-2027 EX $0.01			170,000,000
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105			8,000,000
ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031			62,500,000
ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004			20,166,667
ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003			40,000,200
New class - code to be confirmed : Unlisted options expiring 9 January 2031 ex $0.008			18,000,000

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 5 / 6

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

Part 5 - Other Listing Rule requirements

5.1 Were the +securities issued under an exception in Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing Rule 7.1?

Yes

5.1a Select the number of the applicable exception in Listing Rule 7.2

13

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 6 / 6